TEST BANK FOR TIETZ FUNDAMENTALS OF CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7TH EDITION BY CARL A. BURTIS || ALL 29 CHAPTERS COVERED || A” GUIDE

TEST BANK FOR TIETZ FUNDAMENTALS OF CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7TH EDITION BY CARL A. BURTIS || ALL 29 CHAPTERS COVERED || A” GUIDE TEST BANK FOR TIETZ FUNDAMENTALS OF CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7TH EDITION BY CARL A. BURTIS || ALL 29 CHAPTERS COVERED || A” GUIDE TEST BANK FOR TIETZ FUNDAMENTALS OF CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7TH EDITION BY CARL A. BURTIS || ALL 29 CHAPTERS COVERED || A” GUIDE TEST BANK TIETZ FUNDAMENTALS OF CLINICAL CHEMISTRY AND MOLECULAR DIAGNOSTICS 7TH EDITION BY CARL A. BURTIS Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 7th Edition Test Bank Table of contents: I. Principles Of Laboratory Medicine Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques Chapter 3. Clinical Evaluation of Methods Chapter 4. Evidence-Based Laboratory Medicine Chapter 5. Establishment and Use of Reference Values Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables Chapter 7. Quality Management II. Analytical Techniques And Instrumentation Chapter 8. Principles of Basic Techniques and Laboratory Safety Chapter 9. Optical Techniques Chapter 10. Electrochemistry and Chemical Sensors Chapter 11. Electrophoresis Chapter 12. Chromatography Chapter 13. Mass Spectrometry Chapter 14. Enzyme and Rate Analyses Chapter 15. Immunochemical Techniques Chapter 16 Automation Chapter 17. Point-of-Care Instrumentation III. Analytes Chapter 18. Amino Acids, Peptides, and Proteins Chapter 19. Serum Enzymes Chapter 20. Tumor Markers and Cancer Genes Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid Chapter 22. Carbohydrates Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors Chapter 24. Electrolytes and Blood Gases Chapter 25. Hormones Chapter 26. Catecholamines and Serotonin Chapter 27. Vitamins, Trace Elements, Nutritional Assessment Chapter 28. Hemoglobin, Iron, and Bilirubin Chapter 29. Porphyrins and Porphyrias Chapter 30. Therapeutic Drugs and Their Management Chapter 31. Clinical Toxicology Chapter 32. Toxic Metals IV. Pathophysiology Chapter 33. Diabetes Chapter 34. Cardiovascular Disease Chapter 35. Kidney Disease Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism Chapter 37. Liver Disease Chapter 38. Gastrointestinal and Pancreatic Diseases Chapter 39. Disorders of Bone and Mineral Metabolism Chapter 40. Disorders of the Pituitary Gland Chapter 41. Disorders of the Adrenal Cortex Chapter 42. Thyroid Disorders Chapter 43. Reproduction-Related Disorders Chapter 44. Pregnancy and Prenatal Testing Chapter 45. Newborn Screening and Inborn Errors of Metabolism Chapter 46. Pharmacogenetics V. Molecular Diagnostics Chapter 47. Principles of Molecular Biology Chapter 48. Nucleic Acid Techniques and Applications Chapter 49. Genomes and Nucleic Acid Alterations Tietz Fundamentals of Clinical Chemistry and MolecularDiagnostics, 7e Burtis Test Bank Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory MedicineTest Bank MULTIPLE CHOICE 1. An individual working in a clinical chemistry laboratory is married to a sales representative who works for a company that sells chemistry laboratory supplies. When the laboratory manager requests a list of needed supplies, cost of supplies, and vendors, this individual only recommends the spouse’s company as the vendor. This is considered to be a(n): a. accounting issue. b. possible conflict of interest. c. maintenance of confidentiality issue. d. problem with resource allocation. ANS: B Concern has been raised over the interrelationships between practitioners in the medical field and commercial suppliers of drugs, devices, equipment, etc., to the medical profession. Similarly, relationships have been scrutinized between clinical laboratorians and manufacturers and providers of diagnostic equipment and supplies. These concerns led the National Institutes of Health (NIH) in 1995 to require official institutional review of financial disclosure by researchers and management of situations in which disclosure indicates potential conflicts of interest. DIF: 1 REF: Page 4-5 OBJ: 6 | 7